B. J. Nankivell and S. I. Alexander, Rejection of the kidney allograft, N. Engl. J. Med, vol.363, pp.1451-1462, 2010.

A. Loupy and C. Lefaucheur, Antibody-mediated rejection of solid-organ allografts, N. Engl. J. Med, vol.379, pp.1150-1160, 2018.

Y. Bouatou, D. Viglietti, D. Pievani, K. Louis, J. P. Duong-van-huyen et al., Response to treatment and long-term outcomes in kidney transplant recipients with acute t cell-mediated rejection, Am. J. Transplant, 2019.

Y. Lebranchu, C. Baan, L. Biancone, C. Legendre, J. M. Morales et al., Pretransplant identification of acute rejection risk following kidney transplantation, Transplant. Int, vol.27, pp.129-138, 2014.

D. Cantarovich, F. Vistoli, and J. P. Soulillou, Immunosuppression minimization in kidney transplantation, Front. Biosci, vol.13, pp.1413-1432, 2008.

M. Pascual, T. Theruvath, T. Kawai, N. Tolkoff-rubin, and A. B. Cosimi, Strategies to improve long-term outcomes after renal transplantation, N. Engl. J. Med, vol.346, pp.580-590, 2002.

M. C. Londono, R. Danger, M. Giral, J. P. Soulillou, A. Sanchez-fueyo et al., A need for biomarkers of operational tolerance in liver and kidney transplantation, Am. J. Transplant, vol.12, pp.1370-1377, 2012.

M. C. Clark and L. G. Baum, T cells modulate glycans on cd43 and cd45 during development and activation, signal regulation, and survival, Ann. N. Y. Acad. Sci, vol.1253, pp.58-67, 2012.

M. L. Hermiston, Z. Xu, and A. Weiss, Cd45: A critical regulator of signaling thresholds in immune cells, Annu. Rev. Immunol, vol.21, pp.107-137, 2003.

L. Ordonez, I. Bernard, M. Chabod, J. F. Augusto, V. Lauwers-cances et al., A higher risk of acute rejection of human kidney allografts can be predicted from the level of cd45rc expressed by the recipients' cd8 t cells, PLoS ONE, issue.8, p.69791, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02164657

L. Ordonez, I. Bernard, F. E. ;-l'faqihi-olive, J. W. Tervaert, J. Damoiseaux et al., Cd45rc isoform expression identifies functionally distinct t cell subsets differentially distributed between healthy individuals and aav patients, PLoS ONE, vol.4, p.5287, 2009.

J. F. Subra, B. Cautain, E. Xystrakis, M. Mas, D. Lagrange et al., The balance between cd45rchigh and cd45rclow cd4 t cells in rats is intrinsic to bone marrow-derived cells and is genetically controlled, J. Immunol, vol.166, pp.2944-2952, 2001.

A. S. Garnier, M. Planchais, J. Riou, C. Jacquemin, L. Ordonez et al., Pre-transplant cd45rc expression on blood t cells differentiates patients with cancer and rejection after kidney transplantation, PLoS ONE, vol.14, p.214321, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02100184

M. Haas, B. Sis, L. C. Racusen, K. Solez, D. Glotz et al., meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions, Am. J. Transplant, vol.14, pp.272-283, 2013.

E. Xystrakis, P. Cavailles, A. S. Dejean, B. Cautain, C. Colacios et al., Functional and genetic analysis of two cd8 t cell subsets defined by the level of cd45rc expression in the rat, J. Immunol, vol.173, pp.3140-3147, 2004.

J. Sellares, D. G. De-freitas, M. Mengel, J. Reeve, G. Einecke et al., Understanding the causes of kidney transplant failure: The dominant role of antibodymediated rejection and nonadherence, Am. J. Transplant, vol.12, pp.388-399, 2012.

P. F. Halloran, J. Chang, K. Famulski, L. G. Hidalgo, I. D. Salazar et al., Disappearance of t cell-mediated rejection despite continued antibody-mediated rejection in late kidney transplant recipients, J. Am. Soc. Nephrol, vol.26, pp.1711-1720, 2015.

P. Randhawa, T-cell-mediated rejection of the kidney in the era of donor-specific antibodies: Diagnostic challenges and clinical significance, Curr. Opin. Organ Transplant, vol.20, pp.325-332, 2015.

J. C. Krisl, R. R. Alloway, A. R. Shield, A. Govil, G. Mogilishetty et al., Acute rejection clinically defined phenotypes correlate with long-term renal allograft survival, Transplantation, vol.99, pp.2167-2173, 2015.

C. Lefaucheur, C. Gosset, M. Rabant, D. Viglietti, J. Verine et al., T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts, Am. J. Transplant, vol.18, pp.377-390, 2018.

C. Wiebe, I. W. Gibson, T. D. Blydt-hansen, M. Karpinski, J. Ho et al., Evolution and clinical pathologic correlations of de novo donor-specific hla antibody post kidney transplant, Am. J. Transplant, vol.12, pp.1157-1167, 2012.

F. Moreso, M. Carrera, M. Goma, M. Hueso, J. Sellares et al., Early subclinical rejection as a risk factor for late chronic humoral rejection, Transplantation, vol.93, pp.41-46, 2012.